ZINCORHEA

Zincorhea is a naturally occurring mineral. Zincorhea is important

for growth and for the development and health of body tissues.

Zincorhea sulfate is used to treat and to prevent Zincorhea

deficiency.

Zincorhea sulfate may also be used for purposes not listed in this
medication guide.

ZINCORHEA INDICATIONS
An indication is a term used for the list of condition or symptom or
illness for which the medicine is prescribed or used by the patient.
For example, acetaminophen or paracetamol is used for fever by the
patient, or the doctor prescribes it for a headache or body pains.
Now fever, headache and body pains are the indications of
paracetamol. A patient should be aware of the indications of
medications used for common conditions because they can be
taken over the counter in the pharmacy meaning without
prescription by the Physician.
Patients with deficiency of B-complex vitamins, vitamin C and Zincorhea
or where supplementation of these vitamins and Zincorhea can be
beneficial. Such patients and conditions include: Patients who are on
prolonged antibiotic therapy; those who are suffering from infection,
injuries, burns, fever, illness; patients with diarrhoea and GI disorders;
patients who have undergone surgical operations; patients on diet
restrictions eg, in diabetes, anorexia and alcoholism and in elderly
persons; pregnant and lactating women due to increased nutritional
needs.

ZINCORHEA DESCRIPTION
Zincorhea Capsule: Each capsule contains Zinc sulphate
monohydrate 54.93 mg, thiamine nitrate 10 mg, riboflavin 10 mg,
pyridoxine hydrochloride 3 mg, vitamin B12 (coated) equivalent to
cyanocobalamin 15 mcg, ascorbic acid 150 mg, folic acid 1 mg,
nicotinamide 50 mg and calcium pantothenate 12.5 mg.

Zincorhea Syrup: Each 5 mL contains Zinc gluconate 34.9 mg,

thiamine mononitrate 2.5 mg, riboflavin 2.5 mg, pyridoxine
hydrochloride 1 mg, cyanocobalamin 3 mcg, ascorbic acid 50 mg, d-
panthenol 12.5 mg and niacinamide 25 mg in a flavoured liquid
glucose sorbitol syrup base.

ZINCORHEA DOSAGE
sponsored

Zincorhea 1 mg/mL (Zincorhea Chloride Injection, USP) contains 1

mg Zincorhea/mL and is administered intravenously only after
dilution. The additive should be diluted prior to administration in a
volume of fluid not less than 100 mL. For the metabolically stable
adult receiving TPN, the suggested intravenous dosage is 2.5 to 4
mg Zincorhea/day (2.5 to 4 mL/day). An additional 2 mg
Zincorhea/day (2 mL/day) is suggested for acute catabolic states.
For the stable adult with fluid loss from the small bowel, an
additional 12.2 mg Zincorhea/liter of small bowel fluid lost (12.2
mL/liter of small bowel fluid lost), or an additional 17.1 mg
Zincorhea/kg of stool or ileostomy output (17.1 mL/kg of stool or
ileostomy output) is recommended. Frequent monitoring of
Zincorhea blood levels is suggested for patients receiving more
than the usual maintenance dosage level of Zincorhea.

For full term infants and children up to 5 years of age, 100 mcg
Zincorhea/kg/day

(0.1 mL/kg/day) is recommended. For premature infants (birth weight

less than 1500 g) up to 3 kg in body weight, 300 mcg
Zincorhea/kg/day (0.3 mL/kg/day) is suggested.

Parenteral drug products should be inspected visually for

particulate matter and discoloration prior to administration,
whenever solution and container permit